C
9.04
-0.20 (-2.16%)
| Previous Close | 9.24 |
| Open | 9.24 |
| Volume | 630,401 |
| Avg. Volume (3M) | 818,925 |
| Market Cap | 452,605,376 |
| Price / Sales | 1.96 |
| Price / Book | 0.980 |
| 52 Weeks Range | |
| Earnings Date | 4 Nov 2025 |
| Profit Margin | -46.46% |
| Operating Margin (TTM) | -35.73% |
| Diluted EPS (TTM) | -2.36 |
| Quarterly Revenue Growth (YOY) | 10.10% |
| Total Debt/Equity (MRQ) | 60.85% |
| Current Ratio (MRQ) | 5.56 |
| Operating Cash Flow (TTM) | -17.40 M |
| Levered Free Cash Flow (TTM) | -89.49 M |
| Return on Assets (TTM) | -4.84% |
| Return on Equity (TTM) | -24.97% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Integrated Freight & Logistics (US) | Bullish | Bearish |
| Integrated Freight & Logistics (Global) | Mixed | Bearish | |
| Stock | CryoPort, Inc. | Bearish | Bullish |
AIStockmoo Score
-1.4
| Analyst Consensus | 2.0 |
| Insider Activity | NA |
| Price Volatility | -4.5 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | -0.5 |
| Average | -1.38 |
|
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas. |
|
| Sector | Industrials |
| Industry | Integrated Freight & Logistics |
| Investment Style | Small Value |
| % Held by Insiders | 3.48% |
| % Held by Institutions | 99.07% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Thematics Asset Management | 30 Jun 2025 | 1,914,885 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 15.00 (BTIG, 65.93%) | Buy |
| Median | 12.50 (38.27%) | |
| Low | 12.00 (Needham, 32.74%) | Buy |
| Average | 13.17 (45.69%) | |
| Total | 3 Buy | |
| Avg. Price @ Call | 9.04 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Needham | 05 Nov 2025 | 12.00 (32.74%) | Buy | 8.53 |
| UBS | 05 Nov 2025 | 12.50 (38.27%) | Buy | 8.53 |
| BTIG | 18 Sep 2025 | 15.00 (65.93%) | Buy | 10.05 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 04 Nov 2025 | Announcement | Cryoport Reports Third Quarter 2025 Financial Results |
| 30 Oct 2025 | Announcement | Cryoport Continues to Set New Benchmarks for the Global Regenerative Medicine Supply Chain |
| 21 Oct 2025 | Announcement | Cryoport to Report Third Quarter 2025 Financial Results on November 4, 2025 |
| 07 Oct 2025 | Announcement | MVE Biological Solutions, A Cryoport Company, Introduces Real-Time Integrated Condition Monitoring Systems For Cryogenic Dewars |
| 01 Oct 2025 | Announcement | Cryoport Systems Expands Global Footprint with New Global Supply Chain Center in Paris, France |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |